Concepedia

Albane Courjaud

AC

3

Publications

264

Citations

3

H-Index

2018

Active since

Affiliations

Sanofi (United States)(Current)

Sanofi (France)

Albane Courjaud is an author at Sanofi (United States) specializing in biosynthesis, biochemistry, and natural sciences.

Top concepts

Publications per year

2018–2020

3

Publications

3

Dependence on the Pyrimidine Biosynthetic Enzyme DHODH Is a Synthetic Lethal Vulnerability in Mutant KRAS-Driven Cancers

Malvika Koundinya, Judith Sudhalter, Albane Courjaud et al. · Cell chemical biology · 2018 · 118 citations

, , +5

Discovery of 6-(2,4-Dichlorophenyl)-5-[4-[(3<i>S</i>)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7<i>H</i>-benzo[7]annulene-2-carboxylic acid (SAR439859), a Potent and Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen-Receptor-Positive Breast Cancer

Youssef El‐Ahmad, Michel Tabart, Frank Halley et al. · Journal of Medicinal Chemistry · 2019 · 80 citations · Full text

SAR439859, a Novel Selective Estrogen Receptor Degrader (SERD), Demonstrates Effective and Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models

Maysoun Shomali, Jane Cheng, Fangxian Sun et al. · Molecular Cancer Therapeutics · 2020 · 66 citations · Full text

Rows per page

1–3 of 3